• SENSEX 72,638.70
    -429.11 (--0.59%)
  • BANKNIFTY 55,055.55
    -72.85 (--0.13%)
  • Bharti Airtel
    1,854.95 2,174.70(%)
  • Swiggy
    253.65 460.00(%)
  • Kanohar Elect.
    1,129.35 1,129.35(%)
  • HDFC Bank
    701.60 682.00(%)
  • C P C L
    1,626.80 1,677.00(%)
  • NSE
    1,736.10 1,712.00(%)
  • DLF
    652.25 489.30(%)
  • Divi's Lab.
    9,653.50 10,000.00(%)
  • Moneyview
    60.55 62.00(%)
  • United Spirits
    1,337.65 1,210.40(%)
  • Max Healthcare
    911.00 1,221.10(%)
  • One Mobikwik
    265.90 296.75(%)
  • B H E L
    446.65 229.70(%)
  • Infosys
    990.25 980.30(%)
  • Apollo Hospitals
    7,829.35 6,680.00(%)
  • Hind.Aeronautics
    4,732.40 3,479.20(%)
  • ICICI Lombard
    1,608.50 2,064.15(%)
  • Cupid
    345.05 345.05(%)
  • Rentomojo
    644.15 644.15(%)
  • Hero Motors
    172.80 179.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bal Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4704.0
  • ISIN : INE083D01012
98.62 -3 (-2.80%)
  • As on 07 Oct 2026 (EOD)

  • Today’s Low

    96.39

  • Today’s High

    103.90

  • Open

    99.10

  • Perv Close

    101.46

  • 52W Low

    60.00

  • 52W High

    124.60

Key Indicators

  • P/E(TTM)

    20.38

  • Mar.Cap (₹Cr.)

    157.01

  • Div & Yield %

    1.23

  • Book Value(₹)

    65.39

  • Debt-Equity Ratio

    -2.80

  • AGM Date

    07-Oct-2026

  • EPS

    4.77

  • P/E Ratio

    20.38

Financials Ratios

  • Debt-Equity Ratio

    1.99

  • Mar.Cap (₹Cr.)

    157.01

  • RONW (%)

    10.97

  • ROCE (%)

    11.29

Score Board

  • Equity (₹ in Cr.)

    15.92

  • BV (₹)

    65.40

  • Sales( ₹ in Cr.)

    310.80

  • NP (in Cr.)

    6.70

  • NP Var(%)

    -14.0

  • Div%

    12.0

  • CPS (₹)

    11.20

  • EPS (₹)

    4.20

  • Traded Value (₹ in Lakhs)

    154.75

  • 52 Week High

    124.60

  • 52 Week Low

    60.00

  • Price BSE

    97.0

  • Price NSE

    99.00

  • Market Capital( in Cr.)

    154.75

  • P/C Ratio

    8.70

  • P/E Ratio

    23.10

  • Price Vs.BV

    4.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 310.80 302.50 338.54 303.10 280.37 249.31
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 310.80 302.50 338.54 303.10 280.37 249.31
Other Income 2.00 2.15 2.30 2.19 6.49 2.69
Stock Adjustments 12.25 7.08 1.06 17.90 4.85 -5.13
Total Income 325.05 311.73 341.90 323.19 291.71 246.87
EXPENDITURE :            
Raw Materials 170.10 164.85 192.80 187.83 171.35 145.45
Power and Fuel Cost 9.59 8.29 8.73 6.87 5.37 4.70
Employee Cost 65.92 61.83 59.57 51.56 44.46 39.62
Other Manufacturing Expenses 13.04 10.90 12.95 20.20 14.64 9.12
Selling and Administration Expenses 29.68 33.01 32.27 26.21 21.64 15.44
Miscellaneous Expenses 2.28 0.42 1.56 1.90 4.35 3.24
Employee Benefit Expenses 65.92 61.83 59.57 51.56 44.46 39.62
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 290.61 279.30 307.89 294.56 261.82 217.57
Operating Profit 34.44 32.42 34.01 28.62 29.89 29.30
Interest 17.02 17.04 14.64 12.59 10.60 12.25
Gross Profit 17.42 15.38 19.37 16.03 19.29 17.05
Depreciation 11.06 9.65 10.05 7.48 7.24 7.26
Profit Before Tax 6.36 5.73 9.32 8.55 12.05 9.79
Current Tax 0.00 -0.14 0.76 2.03 5.42 0.38
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.39 -1.93 0.84 0.39 -1.94 0.32
Reported Net Profit 6.75 7.80 7.73 6.13 8.58 9.10
Extraordinary Items 0.06 0.00 0.05 0.03 0.78 0.04
Adjusted Net Profit 6.69 7.80 7.68 6.10 7.80 9.06
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 48.74 42.90 36.74 42.37 35.27 26.18
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.91 1.96 1.57 1.56 1.48 0.00
P & L Balance carried down 53.58 48.74 42.90 46.94 42.37 35.27
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 12.00 12.00 12.00 10.00 10.00 10.00
Dividend Per Share(Rs) 1.20 1.20 1.20 1.00 1.00 1.00
Earnings Per Share-Unit Curr 4.24 4.90 4.89 3.90 5.79 6.14
Earnings Per Share(Adj)-Unit Curr 4.24 4.90 4.89 3.90 5.79 6.14
Book Value 65.39 62.07 58.74 61.21 58.28 52.88
Book Value(Adj)-Unit Curr 65.39 62.07 58.74 61.21 58.28 52.88

Shareholding Pattern

  • Promoter Group

    50.86%

  • Public Share Holding

    49.14%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 655,187 655,187.00 655,187 655,187
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 655,187 4.12 655,187 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,011,736 12.64 2,011,736 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,430,259 34.11 5,430,259 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,441,995 46.74 7,441,995 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 23,489 0.15 23,489 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 23,489 0.15 23,489 3
2] Non Institution
Bodies Corporate 87,945 0.55 87,844 47
Clearing Members 19,043 0.12 19,043 12
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 100 0.00 0 1
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,883,541 11.83 1,874,041 153
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 429,998 2.70 429,998 267
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,575,068 9.89 1,575,068 24
Individuals holding nominal share capital up to Rs. 1 lakh 3,656,505 22.97 3,577,685 14,451
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 141,719 0.89 141,719 1
Sub Total 7,800,201 48.99 7,711,680 14,960
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 15,920,872 100.00 15,832,351 14,974

Company Background

Bal Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Bal Pharma Ltd
  • BSE Code : 4704.0
  • ISIN : INE083D01012

  • Incorporation Year

    1987

  • Registered Office

    21 & 22 Bommasandra Indl Area
    Hosur Road, Bangalore,
    Karnataka-560092

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Abdul Basith

  • Auditor

    SSJNB & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Bal Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bal Pharma 97.20 312.80 310.80 20.38 8.99
Abbott India 26,087.15 7,217.19 6,929.05 34.33 43.78
Astrazeneca Phar 5,918.55 2,304.07 2,275.58 87.23 27.86
Glaxosmi. Pharma 2,633.25 3,932.76 3,790.20 42.06 58.17
Novartis India 2,011.30 393.10 354.33 50.79 15.94
Cipla 1,329.50 20,102.60 18,979.95 34.94 13.88
Bliss GVS Pharma 677.95 773.53 729.81 63.01 12.51
Fermenta Biotec. 566.40 474.15 450.25 26.44 18.77
Amrutanjan Healt 521.45 520.13 502.55 27.93 24.16
Guj. Themis Bio. 379.75 168.25 165.82 101.54 18.05
Ambalal Sarabhai 40.07 19.52 3.94 74.20 6.77